Seeds of hope
Hybrid seeds produced at the research labs of Maharashtra Hybrid Seeds Co Ltd. (Mahyco) are not just
contributing enormously to the growth of Indian agricultural sector but also adding to the gene research
capabilities of the country.
Major advance in sleeping sickness drug made by Glasgow scientists.
Scientists have made a key advance in developing a safer cure for sleeping sickness.
Plants could pave the way for new ovarian cancer treatments.
Tropical plants may contain the basis of new and effective treatments for ovarian cancer, according to
researchers at the Universities of Strathclyde and Portsmouth in the UK.
New data for use of Lantus in patients with Type 2 Diabetes.
Sanofi recently announced data that demonstrates that initiating Lantus (insulin glargine [rDNA origin]
injection) in type 2 diabetes patients leads to better glycemic control and comparable and modest weight gain versus a comparator group consisting of other insulins, oral antidiabetics (OADs) and dietary changes.
AiCuris’ HCMV Drug Letermovir receives fast track from FDA.
AiCuris announced recently that the US FDA has granted Fast Track designation for one of the company’s lead drugs, AIC246 (INN: Letermovir), an inhibitor of the human cytomegalovirus (HCMV).
-Expresspharma
Courtesy
Mr. Palak Motan
National Institute of Pharmaceutical Education and Research(NIPER)
Ahmedabad
Hybrid seeds produced at the research labs of Maharashtra Hybrid Seeds Co Ltd. (Mahyco) are not just
contributing enormously to the growth of Indian agricultural sector but also adding to the gene research
capabilities of the country.
Major advance in sleeping sickness drug made by Glasgow scientists.
Scientists have made a key advance in developing a safer cure for sleeping sickness.
Plants could pave the way for new ovarian cancer treatments.
Tropical plants may contain the basis of new and effective treatments for ovarian cancer, according to
researchers at the Universities of Strathclyde and Portsmouth in the UK.
New data for use of Lantus in patients with Type 2 Diabetes.
Sanofi recently announced data that demonstrates that initiating Lantus (insulin glargine [rDNA origin]
injection) in type 2 diabetes patients leads to better glycemic control and comparable and modest weight gain versus a comparator group consisting of other insulins, oral antidiabetics (OADs) and dietary changes.
AiCuris’ HCMV Drug Letermovir receives fast track from FDA.
AiCuris announced recently that the US FDA has granted Fast Track designation for one of the company’s lead drugs, AIC246 (INN: Letermovir), an inhibitor of the human cytomegalovirus (HCMV).
-Expresspharma
Courtesy
Mr. Palak Motan
National Institute of Pharmaceutical Education and Research(NIPER)
Ahmedabad
I think the pharma research is somewhat related to the biotech research especially biopharmaceutical research. Do you agree?
ReplyDelete